Cytokinetics Incorporated

NASDAQ: CYTKHealthcare / Biotechnology / USA
10.82-0.3800-3.39%Vol 337 7231Y Perf 29.46%
Jun 24th, 2019 16:00
BID9.86 ASK11.30
Open11.20 Previous Close11.20
Pre-Market- After-Trading11.00
 - -%  0.18 1.66%
Target Price
16.00 
Analyst Rating
Strong Buy 1.50
Potencial %
47.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
+ —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
     26.89
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)625 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
88.48 
Earnings Date
25th Jul 2019

Today's Price Range

10.7811.37

52wk Range

5.7511.48

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
7.66%
3 Months
22.40%
6 Months
83.08%
1 Year
29.46%
3 Years
19.69%
5 Years
119.92%

Name / TickerPriceChg.Chg.%
CYTK10.82-0.3800-3.39
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.47-0.54-14.89
Q04 2018-0.55-0.4812.73
Q03 2018-0.53-0.4024.53
Q02 2018-0.49-0.51-4.08
Q01 2018-0.53-0.56-5.66
Q04 2017-0.71-0.75-5.63
Q03 2017-0.64-0.606.25
Q02 2017-0.66-0.609.09
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.53-12.77Negative
9/2019 QR-0.49-11.36Negative
12/2019 FY-1.85-5.71Negative
12/2020 FY-1.75-1.16Negative
Next Report Date25th Jul 2019
Estimated EPS Next Report-0.53
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume337 723
Shares Outstanding (in ths.)57 721
Trades Count1 592
Dollar Volume3 152 929
Avg. Volume535 664
Avg. Weekly Volume411 044
Avg. Monthly Volume438 416
Avg. Quarterly Volume504 777
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

CEO: Robert I. Blum

Teplephone: +1 650 624-3000

Address: 280 East Grand Avenue, South San Francisco 94080, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

72%28%

Bearish Bullish

63%37%

News